Evidence map›Paper›PMID 40267072›Full record

ArticlePloS one2025

Evaluation of intake of aged garlic extract and organosulfur compounds on progressive hearing loss in DBA/2J mice.

Hideaki Oike, Kyoko Yamasaki, Kenji Hashiguchi, Honoka Uehira

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Hideaki OikeInstitute of Livestock and Grassland Science, National Agriculture and Food Research Organization (NARO), Tsukuba, Ibaraki, Japan.
Kyoko YamasakiResearch and Development Department, Momoya Co., Ltd., Tokyo, Japan.
Kenji HashiguchiResearch and Development Department, Momoya Co., Ltd., Tokyo, Japan.
Honoka UehiraResearch and Development Department, Momoya Co., Ltd., Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Garlic is rich in organosulfur compounds with high antioxidant capacity and is known to have various health benefits. Aged garlic is a particularly effective source of these active compounds because it contains fewer toxic components. This study evaluated the effects of S-allyl cysteine (SAC), a major functional organosulfur compound in garlic, and aged garlic extract (AGE) on the suppression of progressive hearing loss. SAC and AGE were dissolved in drinking water at 1% (w/w) and administered to DBA/2J mice, a model of early progressive hearing loss, for 12 weeks, starting at 4 weeks of age. While the results revealed a trend toward weight loss in the SAC group, the weight of the AGE group was comparable to that of the control group, and no adverse events were observed in either group. The hearing ability of the mice was measured using auditory brainstem responses at 4, 8, 12, and 16 weeks of age. Hearing loss at 8 and 16 kHz progressed over the 12-week period, with neither sample inhibiting hearing loss. In contrast, another organosulfur compound, N-acetylcysteine (NAC), administered in 1% w/w drinking water and evaluated for hearing loss over time, significantly suppressed hearing loss progression in DBA/2J mice. These results indicate that the NAC and SAC differ in their ability to prevent hearing loss and demonstrate that the inhibitory effects of functional food components on hearing loss can be evaluated over a short period in DBA/2J mice.

Indexed as

CysteineGarlicHearing LossPlant ExtractsSulfur CompoundsAcetylcysteineAnimalsEvoked Potentials, Auditory, Brain StemMaleMiceMice, Inbred DBAAcetylcysteineCysteinePlant ExtractsS-allylcysteineSulfur Compounds

Identifiers

PMID40267072
PMCPMC12017496

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.